Contribution of Syndecans to the Cellular Entry of SARS-CoV-2

by Anett Hudák, Annamária Letoha, László Szilák, Tamás Letoha
Published 2021-05-01

The Interplay of Apoes with Syndecans in Influencing Key Cellular Events of Amyloid Pathology

by Anett Hudák, Katalin Jósvay, Ildikó Domonkos, Annamária Letoha, László Szilák, Tamás Letoha
Published 2021-06-01

The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.

by Aniko Keller-Pinter, Bettina Ughy, Monika Domoki, Aladar Pettko-Szandtner, Tamas Letoha, Jozsef Tovari, Jozsef Timar, Laszlo Szilak
Published 2017-01-01

Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration.

by Fang Zong, Eleni Fthenou, Filip Mundt, Tünde Szatmári, Ilona Kovalszky, László Szilák, David Brodin, George Tzanakakis, Anders Hjerpe, Katalin Dobra
Published 2011-01-01

Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells.

by Fang Zong, Eleni Fthenou, Nina Wolmer, Péter Hollósi, Ilona Kovalszky, László Szilák, Carolin Mogler, Gustav Nilsonne, Georgios Tzanakakis, Katalin Dobra
Published 2009-10-01

Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1

by Péter Hollósi, Lóránd Váncza, Katalin Karászi, Katalin Dobos, Bálint Péterfia, Enikő Tátrai, Péter Tátrai, Tibor Szarvas, Sándor Paku, László Szilák, Ilona Kovalszky
Published 2020-09-01

Overexpression of Human Syndecan-1 Protects against the Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice

by Andrea Reszegi, Katalin Karászi, Gábor Tóth, Kristóf Rada, Lóránd Váncza, Lilla Turiák, Zsuzsa Schaff, András Kiss, László Szilák, Gábor Szabó, Gábor Petővári, Anna Sebestyén, Katalin Dezső, Eszter Regős, Péter Tátrai, Kornélia Baghy, Ilona Kovalszky
Published 2021-03-01